| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |